Blast crisis of chronic granulocytic leukemia. Morphologic variants and therapeutic implications

Susan Rosenthal, George P. Canellos, Jacqueline Whang-Peng, Harvey R. Gralnick

Research output: Contribution to journalArticlepeer-review

102 Citations (Scopus)


Chronic granulocytic leukemia (CGL) terminates in a disease similar to acute leukemia. Except for a study indicating an increased response rate to the drugs, vincristine and prednisone, therapy of this terminal phase has been universally disappointing. We have studied the bone marrows and clinical courses of 67 patients in the terminal phase of CGL to discern if any parameters were associated with an increased response rate or survival. The results of this study indicate that patients who have a lymphoblastic morphology or hypodiploid cytogenetics in the terminal phase respond better to treatment with the combination of vincristine and prednisone than those with myeloblastic morphology or hyperdiploid cytogenetics. Response rate and survival are significantly increased in those with lymphoblastic morphology. Recognition of the heterogeneity of the terminal phase of CGL may dictate specific therapeutic modalities.

Original languageEnglish
Pages (from-to)542-547
Number of pages6
JournalThe American Journal of Medicine
Issue number4
Publication statusPublished - Jan 1 1977
Externally publishedYes

ASJC Scopus subject areas

  • General Nursing


Dive into the research topics of 'Blast crisis of chronic granulocytic leukemia. Morphologic variants and therapeutic implications'. Together they form a unique fingerprint.

Cite this